Skip to main content
. 2020 Dec 15;2(5):747–754. doi: 10.1016/j.jaccao.2020.09.008

Central Illustration.

Central Illustration

Anticoagulation Decision Making in Cancer Patients With Atrial Fibrillation

Anticoagulation for atrial fibrillation–related thromboembolism prophylaxis can be challenging in patients with concurrent cancer. In this population, decision making must be individualized weighing factors that promote the use of anticoagulation against those unique cancer-specific circumstances that are likely to increase bleeding risk and other complications. CVA = cerebrovascular accident.